| |
| |
|
| Insider
Information: |
Canan John |
| Relationship: |
Director |
| City: |
Whitehouse Station |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
173,283 |
|
|
Indirect Shares
|
3,345 |
|
|
| Direct
Value |
$3,116,978 |
|
|
|
Indirect Value
|
$437,258 |
|
|
| Total
Shares |
176,628 |
|
|
| Total
Value |
$3,554,236 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Merck & Co Inc |
MRK |
Sr.V-P Finc-Global Con... |
2014-02-24 |
13,609 |
2014-02-24 |
3,345 |
Premium* |
|
|
Rev Group, Inc. |
REVG |
Director |
2023-12-08 |
59,674 |
2017-01-26 |
0 |
Premium* |
|
|
Acasti Pharma Inc |
ACST |
Director |
2020-04-01 |
100,000 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| REVG |
Rev Group, Inc. |
Director |
– • – |
2023-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
7,084 |
59,674 |
0 |
- |
|
| REVG |
Rev Group, Inc. |
Director |
– • – |
2022-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
7,960 |
52,590 |
0 |
- |
|
| REVG |
Rev Group, Inc. |
Director |
– • – |
2021-12-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,945 |
44,630 |
0 |
- |
|
| REVG |
Rev Group, Inc. |
Director |
– • – |
2020-12-11 |
4 |
A |
$0.00 |
$0 |
D/D |
10,584 |
38,685 |
0 |
- |
|
| ACST |
Acasti Pharma Inc |
Director |
– • – |
2020-04-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
100,000 |
|
% |
|
| REVG |
Rev Group, Inc. |
Director |
– • – |
2019-12-18 |
4 |
A |
$0.00 |
$0 |
D/D |
7,797 |
25,299 |
0 |
- |
|
| REVG |
Rev Group, Inc. |
Director |
– • – |
2019-01-09 |
4 |
A |
$0.00 |
$0 |
D/D |
11,099 |
17,502 |
0 |
- |
|
| REVG |
Rev Group, Inc. |
Director |
– • – |
2018-06-25 |
4 |
B |
$16.04 |
$80,845 |
D/D |
5,040 |
6,363 |
2.39 |
- |
|
| REVG |
Rev Group, Inc. |
Director |
– • – |
2018-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,842 |
28,101 |
0 |
- |
|
| ACST |
Acasti Pharma Inc |
Director |
– • – |
2017-02-21 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
40,000 |
|
- |
|
| REVG |
Rev Group, Inc. |
Director |
– • – |
2017-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
1,363 |
1,363 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Sr.V-P Finc-Global Controller |
• • – |
2014-02-24 |
4 |
A |
$56.18 |
$163,652 |
D/D |
2,913 |
13,610 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Sr.V-P Finc-Global Controller |
• • – |
2014-02-11 |
4 |
S |
$55.70 |
$557,002 |
D/D |
(10,000) |
10,697 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Sr.V-P Finc-Global Controller |
• • – |
2014-02-11 |
4 |
OE |
$48.24 |
$482,400 |
D/D |
10,000 |
20,697 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Sr.V-P Finc-Global Controller |
• • – |
2013-05-07 |
4 |
D |
$44.98 |
$75,072 |
D/D |
(1,669) |
10,550 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Sr.V-P Finc-Global Controller |
• • – |
2013-05-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,479 |
12,219 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Sr.V-P Finc-Global Controller |
• • – |
2013-02-25 |
4 |
A |
$42.52 |
$112,976 |
D/D |
2,657 |
7,715 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Sr.V-P Finc-Global Controller |
• • – |
2012-08-01 |
4 |
S |
$44.29 |
$1,350,787 |
D/D |
(30,500) |
5,058 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Sr.V-P Finc-Global Controller |
• • – |
2012-07-24 |
4 |
D |
$43.27 |
$152,310 |
D/D |
(3,520) |
35,558 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Sr.V-P Finc-Global Controller |
• • – |
2012-07-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
9,681 |
39,078 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Sr.V-P Finc-Global Controller |
• – – |
2012-02-28 |
4 |
A |
$38.38 |
$163,806 |
D/D |
4,268 |
25,171 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Sr.V-P Finc-Global Controller |
• – – |
2011-02-28 |
4 |
D |
$32.19 |
$57,942 |
D/D |
(1,800) |
20,040 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Sr.V-P Finc-Global Controller |
• – – |
2011-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,950 |
21,840 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Sr.V-P Finc-Global Controller |
• – – |
2011-02-22 |
4 |
A |
$32.34 |
$121,631 |
D/D |
3,761 |
16,890 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Sr V-P & Controller |
• – – |
2010-03-02 |
4 |
D |
$37.27 |
$50,836 |
D/D |
(1,364) |
12,552 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
